RO — Roche Holding AG Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Roche Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	15,068	14,935	13,531	12,358	9,187
Depreciation
Amortisation
Non-Cash Items	6,227	7,718	8,655	6,795	11,722
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-7,287	-6,120	-8,227	-6,522	-4,238
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	18,566	20,976	17,803	16,095	20,094
Capital Expenditures	-6,690	-4,549	-4,552	-4,649	-5,009
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,377	-2,003	1,628	-5,994	-6,384
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-9,067	-6,552	-2,924	-10,643	-11,393
Financing Cash Flow Items	-1,992	-2,333	-2,340	-615	-1,115
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-9,666	-13,108	-16,275	-4,239	-6,819
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-348	1,123	-1,859	385	1,599